BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36430705)

  • 1. MT1-MMP Expression Levels and Catalytic Functions Dictate LDL Receptor-Related Protein-1 Ligand Internalization Capacity in U87 Glioblastoma Cells.
    Pratt J; Haidara K; Annabi B
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells.
    Pratt J; Roy R; Annabi B
    Glycobiology; 2012 Sep; 22(9):1245-55. PubMed ID: 22692046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of MTCBP-1 interaction with the cytoplasmic domain of MT1-MMP: Implications in the autophagy cell index of high-grade glioblastoma.
    Pratt J; Iddir M; Bourgault S; Annabi B
    Mol Carcinog; 2016 Feb; 55(2):148-60. PubMed ID: 25640948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual functions of ARP101 in targeting membrane type-1 matrix metalloproteinase: Impact on U87 glioblastoma cell invasion and autophagy signaling.
    Desjarlais M; Annabi B
    Chem Biol Drug Des; 2019 Mar; 93(3):272-282. PubMed ID: 30291676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells.
    Rozanov DV; Hahn-Dantona E; Strickland DK; Strongin AY
    J Biol Chem; 2004 Feb; 279(6):4260-8. PubMed ID: 14645246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
    Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
    FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MT1-MMP/NF-kappaB signaling axis as a checkpoint controller of COX-2 expression in CD133+ U87 glioblastoma cells.
    Annabi B; Laflamme C; Sina A; Lachambre MP; Béliveau R
    J Neuroinflammation; 2009 Mar; 6():8. PubMed ID: 19272160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells.
    Djediai S; Gonzalez Suarez N; El Cheikh-Hussein L; Rodriguez Torres S; Gresseau L; Dhayne S; Joly-Lopez Z; Annabi B
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
    Belkaid A; Fortier S; Cao J; Annabi B
    Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in U87 glioblastoma cells.
    Proulx-Bonneau S; Pratt J; Annabi B
    J Neurooncol; 2011 Aug; 104(1):33-43. PubMed ID: 21088866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells.
    Pratt J; Annabi B
    Cell Signal; 2014 May; 26(5):917-24. PubMed ID: 24462646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMP-mediated proMMP-2 activation.
    Sina A; Lord-Dufour S; Annabi B
    Cancer Lett; 2009 Jul; 279(2):171-6. PubMed ID: 19264392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors.
    Djerir D; Iddir M; Bourgault S; Lamy S; Annabi B
    Biophys Chem; 2018 Mar; 234():34-41. PubMed ID: 29407769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.
    Annabi B; Rojas-Sutterlin S; Laflamme C; Lachambre MP; Rolland Y; Sartelet H; Béliveau R
    Mol Cancer Res; 2008 Jun; 6(6):907-16. PubMed ID: 18567795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium.
    Bruney L; Conley KC; Moss NM; Liu Y; Stack MS
    Biol Chem; 2014 Oct; 395(10):1221-31. PubMed ID: 25205731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Concanavalin-A-Mediated Cytoskeleton Disruption on Low-Density Lipoprotein Receptor-Related Protein-1 Internalization and Cell Surface Expression in Glioblastomas.
    Nanni SB; Pratt J; Beauchemin D; Haidara K; Annabi B
    Biomark Cancer; 2016; 8():77-87. PubMed ID: 27226736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.
    Sabbota AL; Kim HR; Zhe X; Fridman R; Bonfil RD; Cher ML
    Cancer Res; 2010 Jul; 70(13):5558-66. PubMed ID: 20551048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion.
    Vinnakota K; Hu F; Ku MC; Georgieva PB; Szulzewsky F; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Lehnardt S; Hanisch UK; Synowitz M; Markovic D; Wolf SA; Glass R; Kettenmann H
    Neuro Oncol; 2013 Nov; 15(11):1457-68. PubMed ID: 24014382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.
    Su G; Blaine SA; Qiao D; Friedl A
    Cancer Res; 2008 Nov; 68(22):9558-65. PubMed ID: 19010933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.
    Jiang B; Liu J; Lee MH
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.